A trial of the intraperitoneal administration of recombinant interferon-.BETA. for the prevention of the postoperative peritoneal recurrence in gastric cancer with serosal invasion. | Zendy

AI Assistant Blog Pricing

A trial of the intraperitoneal administration of recombinant interferon-.BETA. for the prevention of the postoperative peritoneal recurrence in gastric cancer with serosal invasion.

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.